ECT for Teens: Hope or Harm? A Parent's Guide to Understanding the Treatment
"Navigating the Complexities of Electroconvulsive Therapy for Adolescents: Insights from Parents' Experiences"
Electroconvulsive therapy (ECT) is a treatment that often evokes strong reactions, especially when the discussion involves children and adolescents. It's a procedure where electrical currents are passed through the brain to trigger a brief seizure, aiming to relieve symptoms of certain mental illnesses. Given the intensity and the historical stigma, ECT is typically considered when other treatments have not provided relief.
Globally, the use of ECT in young individuals is infrequent. Data from developed countries such as the United States and Turkey indicate that only a small fraction of all ECT administrations are for those under 18. However, in some parts of Asia, the percentage is notably higher, prompting a closer look at the circumstances and outcomes.
To provide clarity, a recent study explored the experiences of parents whose adolescents underwent ECT for severe mental illnesses. This qualitative research sheds light on parental perspectives, satisfaction levels, and the decision-making process surrounding this controversial treatment.
The Youth Mental Health Landscape
CDC data provide a recent snapshot of adolescent mental health and well-being in the United States. The 2023 National Survey of Children’s Health found that more than 5.3 million adolescents ages 12–17, or 20.3% of adolescents, had a current diagnosed mental or behavioral health condition involving anxiety, depression, or behavior/conduct problems. The CDC Mental Health Data Channel combines recent national- and state-level data to show mental-health trends among youth and adults.
From Controversy to Clinical Guidelines
ECT’s history reflects an ongoing interaction between scientific development, ethical debate, and efforts to improve mental-health treatment. The American Academy of Child and Adolescent Psychiatry established an adolescent ECT practice parameter requiring consideration of diagnosis, symptom severity, and lack of treatment response. In child and adolescent psychiatry, ECT has been identified as particularly relevant for treatment-refractory or life-threatening depression, mania, and catatonia. Despite that role, many child and adolescent psychiatrists report limited knowledge and comfort with ECT.
When Is ECT Considered for Adolescents?
According to the study, ECT was usually considered after other treatments, such as medication and therapy, had failed to provide adequate relief. Parents often described their children's conditions as "bad" or "very bad" before ECT, noting symptoms like aggression, self-abuse, and an inability to manage daily life. These adolescents had typically undergone multiple medication changes and consultations with various professionals, underscoring the severity and treatment resistance of their conditions.
- Open Communication: Discuss all concerns and questions with the treatment team.
- Seek Support: Connect with other families who have experience with ECT.
- Understand the Process: Educate yourself about what ECT involves, including potential side effects and benefits.
What Current Research Shows
Under 21 CFR 882.5940, ECT devices are classified as Class II with special controls when intended for catatonia or a severe major depressive episode associated with major depressive disorder or bipolar disorder in patients age 13 and older who are treatment-resistant or require a rapid response. Recent research continues to examine how ECT works for adolescents compared with adults, including its effectiveness and cognitive effects. One 2024 study specifically stated that more evidence is needed to validate ECT against conventional medication therapy for adolescents with major depression and suicidal ideation.
Evidence and Cognitive Concerns
A systematic review of ECT for treatment-resistant mood disorders in children and adolescents found that most available studies were case series. Because of that evidence base, the reviewers used the Joanna Briggs Institute Case Series Critical Appraisal tool to assess study quality. This reliance on case series limits how confidently researchers can generalize findings about benefits and risks across adolescents.
Reported Side Effects
In a retrospective cohort study of youth treated with ECT, the most commonly reported side effects were headache and memory problems. Headache was reported in 75% of patients, while memory problems were reported in 65%. One patient experienced tardive seizures, showing why treatment comparisons should consider both potential benefit and adverse effects.
Making Informed Decisions About ECT
The study suggests that ECT, when administered thoughtfully and with informed consent, can be a valuable option for adolescents with severe mental illness. Parents generally reported satisfaction with the outcomes, highlighting the importance of comprehensive evaluation, detailed communication, and respecting parental autonomy in treatment decisions.
Efficacy With Unresolved Concerns
A 2026 review of ECT for adolescents reported that the majority of reviewed literature supports efficacy in treating adolescent mental disorders. The same review identified memory impairment and insufficient documentation of side effects as barriers to the ethical use of ECT in adolescents. Taken together, the literature presents ECT as a potentially effective treatment while leaving important questions about cognitive risks and their documentation unresolved.
Stigma and Limited Access
ECT has been used in pediatric patients for more than 80 years, but it remains uncommon and stigmatized. Clinical reports describe its use for severe, treatment-resistant conditions in children and adolescents, including major depressive disorder with suicidal symptoms. In a study of 424 patients ages 16–30 receiving acute-course ECT, age was not a significant predictor of improvement in depression, overall self-reported mental health, or change in cognition. These findings support continued consideration of ECT while highlighting the need for clinicians to understand its indications and limitations.